Professional Documents
Culture Documents
SCIENTIFIC PAPERS
Joe Pozdol, MLIS
Evans Whitaker, MD, MLIS
Norris Medical Library
University of Southern California
2003 Zonal Ave.
Los Angeles, CA 90089-9130
pozdol@usc.edu
ewhitake@usc.edu
Before We Begin
Ask!
PowerPoint at www.usc.edu/nml under
Key Resources for Students
Interactive questions
Handouts
Article later
Evaluation
Unwanted handouts
PART I
SECTIONS OF A PUBLISHED
SCIENTIFIC PAPER
Part I Objectives
Learn the basic structure of papers
Develop an approach to reading papers
Learn how to interpret an article citation
Abstract
Discussion
Introduction
Methods
Results
Abstract
Summarizes
Often only part read
Dont act on abstracts alone
Structured abstracts are norm
Background
Methods
Results
Conclusions
Introduction
Context
What is known
Supporting literature (citations)
Gaps in literature
The research question
Newness
Relevance to field
Methods
Steps taken to
gather data
analyze data
Statistical methods
Not a cookbook
Replicable
Results
Report of data
Tables and graphs
Statistical results
No interpretation
Discussion
Interpretation of results
Answer to research question
Goals met?
Often includes
relation to previous research
limitations
future directions
Abstract
Discussion
Introduction
Methods
Results
Abstract
Discussion
Introduction
Methods
Results
References
List of sources cited in intro
Usually other journal articles
Previous studies in same field
Citation styles differ depending on
field of study (e.g. AMA vs. APA)
journal
Journal
Volume Number
Issue Number
Researchers Article
1. True
2. False
PART II
TYPES OF SCIENTIFIC PAPERS
Part II Objectives
Learn the common study types
Be able to extract the research question
Be able to identify an articles study type
Be able to determine the conclusions
Study Designs
Primary Literature
oObservational
Case-Control
Cohort
oExperimental
Randomized Control Trial
Secondary Literature
oNarrative
(Subject/Journalistic)
Reviews
oSystematic Review
oMeta Analysis
Case-Control
Patients with a disease or exposure
--compared to-Similar group without disease or exposure
Best uses
o
o
Rare conditions
Diseases or conditions that may take a long
time to develop
Background: DES
Used in the United States from 1947 until 1971
Boston area doctors noted an unusual cancer
Study compared the group with the cancer to
similar people without the cancer
The major difference between the cases and the
controls was DES exposure
3.
4.
To reduce socioeconomic
differences
To examine whether the
cancer was related to
infectious disease exposures
To decide if chemical
disinfectants used to clean
wards caused cancer
All of the above
Cohort
Two groups compared over time
One group with exposure,
the other without the
exposure
Best used:
o when exposures cant be controlled
o when outcomes occur infrequently
o when RCT is not ethical
1954
1966
1978
1991
24,007
2,407
257
107
7
100%
80%
60%
40%
20%
none
30
Narrative (Journalistic/Subject)
Reviews
The traditional or classic review
Review limit in Ovid/PubMed includes:
Narrative reviews
Systematic reviews
Systematic Review
Reproducible methods to find and select
articles are included
Should include both inclusion and exclusion
criteria
Why? Decrease author bias
$500-$1000
$300-$500
$200-$300
$100-$200
30
Meta Analysis
Similar to Systematic Review except
Numeric data from separate studies
combined in meta analysis
Uses statistical/mathematical methods to
combine numerical data from studies
Combining data increases the confidence
we have in the conclusions reached by a
meta analysis
GROUP WORK
Group Work
Groups of 3
Everyone in group gets same article (#1, 2, 3, OR 4)
Spend 10 min. working together on questions
Class discussion
ADDITIONAL SLIDES
Article Type
What kind of
question is it
good for?
Strengths
Weaknesses
Identifying
Characteristics
Case-Control
(Herbst, 1971)
(Peled, 2008)
-Rare disorders or
conditions
-Slow developing
disorders
-Causation*
-Susceptible to bias
-Limited validity
-Cross sectional
Cohort**
(Doll, et al, 2004)
(Metcalf, 2008)
- Prognosis
-Causation*
- Feasible when
studying conditions
or exposures over
which the
investigator has no
control
-Susceptible to bias
-Limited validity
-May require large
groups, long
durations, great
cost
-Longitudinal
-Usually
prospective
-Can be
retrospective (less
cost)
Randomized Control
Trial (RCT)
(An et al, 2008)
(Gordon, 1997)
-Drug treatment
-Medical
interventions
-Strong level of
evidence
-Low susceptibility
to bias
-Feasibility (e.g.
Ethical limitations)
-Generalizability**
-Randomization
method
-Experimental and
control groups
Systematic Review
(Techakehakij,2008)
(Gallicchio, 2008)
-Drug treatment
-Medical
interventions
-Low susceptibility
to bias
-Strongest level of
evidence
-Methods section
has explicit
information about
information
sources, how
articles were
chosen or excluded
References
An, L.C., Klatt, C., Perry, C.L., Lein, E.B., Hennrikus, D.J., et al.
(2008). The RealU online cessation intervention for college
smokers: a randomized control trial. Preventive Medicine,
47(2)194-199.
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004). Mortality in
Relation to Smoking: 50 years' observations on male British
doctors. BMJ, doi:10.1136/bmj.38142.554479.AE
Gallicchio, L., Boyd, K., Matanoski, G., et al. (2008). Carotenoids
and the risk of developing lung cancer: A systematic review.
Am.J.Clin. Nutrit., 88, 372-383.
Gordon, C.M., Carey, M.P., & Carey, K.B. (1997). Effects of a
drinking event on behavioral skills and condom attitudes in
men:
Implications for HIV risk from a controlled experiment.
Health Psychology, 16(5), 490-495.
Greenhalgh, T. (2006). How to read a paper: the basis of evidencebased medicine. Malden, MA: Blackwell.
Guyatt, G., Rennie, D. (eds.). (2001). Users guides to the medical
literature: essentials of evidence-based clinical practice.
Chicago: AMA Press.
References